RPE65 and retinal degeneration: We next examined potential efficacies of KUS121 on photoreceptors in the later stage of disease; daily oral administration of KUS121 was started with 13-month-old rd12 mice, when retinal degeneration had already progressed (Supplementary Fig. S1b).